Phase I NT-501 Ciliary Neurotrophic Factor Implant Trial for Primary Open-Angle Glaucoma: Safety, Neuroprotection, and Neuroenhancement

Ophthalmology Science(2023)

引用 0|浏览2
暂无评分
摘要
Proprietary or commercial disclosure may be found after the references.
更多
查看译文
关键词
Glaucoma,Neuroprotection,Neuroenhancement,Neurotrophic factor
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要